RESULTS
• �.intranasal corticosteroids offer a small but significant symptomatic benefit in acute sinusitis. This effect is most marked when patients are given longer durations of treatment (�� days) and g g ( y ) higher doses of the medication. • �.trials reported no serious adverse events associated with intranasal corticosteroid use and no increase in frequency of nonserious adverse events compared with placebo.
• �.the corticosteroid group had a significantly higher subjective level of work performance. • �.evidence of a dose-response relation-ship for mometasone furoate nasal spray: larger doses were associated with a greater likelihood of symptom resolution. we recommend doses of ��� μg of mometasone furoate daily.
